World Hepatitis Day 2026: UAE's Strategic Leadership in Hepatitis Elimination
Dr. Ajay Singh
Lina Osama Zaki Quteineh
Consultant Medical Genetics | DHA Registration ID: 9294403
DNA Labs UAE, Dubai Healthcare City
Executive Summary
World Hepatitis Day 2026, observed on July 28, carries the theme "Hepatitis: Let's Break It Down" — a global call to dismantle the financial, social, and systemic barriers preventing hepatitis elimination . With 287 million people living with chronic hepatitis B or C and 1.3 million annual deaths, the World Health Organization (WHO) emphasizes that elimination is achievable through proven tools: vaccination, accurate diagnostics, and curative treatments . The UAE stands as a regional leader, having integrated hepatitis B vaccination into its national immunization program since 1991, achieving 98% vaccination coverage . This blog post explores the clinical landscape of viral hepatitis, the UAE's proactive strategy, and the critical role of early detection in saving lives.
Physician Insight
"Viral hepatitis is a silent progressive disease — often asymptomatic until significant liver damage has occurred. The UAE's robust screening framework, including mandatory testing for certain groups and nationwide vaccination, is a public health triumph. However, individual awareness remains the cornerstone. Knowing your hepatitis status is not just a personal health measure; it is a community responsibility. I urge everyone to consult their healthcare provider about appropriate screening."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics
Understanding the Hepatitis Spectrum: From A to E
Viral hepatitis refers to inflammation of the liver caused by viral infections. The five main strains — Hepatitis A, B, C, D, and E — differ significantly in transmission routes, disease course, and long-term consequences . Hepatitis B, C, and D are classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC), with chronic infection being a major risk factor for liver cancer .
| Type | Transmission | Clinical Significance |
|---|---|---|
| Hepatitis A | Fecal-oral (contaminated food/water) | Acute infection; does not cause chronic liver disease |
| Hepatitis B (HBV) | Blood, sexual contact, perinatal | Can become chronic; leading cause of cirrhosis and liver cancer |
| Hepatitis C (HCV) | Bloodborne (unsafe injections, transfusions) | High rate of chronicity; leading cause of liver transplant |
| Hepatitis D (HDV) | Bloodborne (co-infection with HBV) | Only occurs with HBV; accelerates liver damage |
| Hepatitis E | Fecal-oral, zoonotic | Acute; can be severe in pregnant women |
UAE's Strategic Commitment to Hepatitis Elimination
The UAE has consistently prioritized viral hepatitis as a strategic health concern, positioning itself as a regional leader in prevention, early detection, and treatment . According to the Ministry of Health and Prevention (MoHAP), the nation's comprehensive strategy rests on four pillars: raising community awareness, fostering cross-sector collaboration, developing evidence-based policies, and implementing forward-looking preventive measures .
Vaccination: A Historic Milestone
The UAE was one of the first countries in the Middle East to include the hepatitis B vaccine in its national immunization schedule, starting in 1991 . Today, vaccination coverage for hepatitis has reached an impressive 98%, a testament to the country's proactive, prevention-driven approach . Healthcare workers and travelers to endemic areas also receive the vaccine as part of occupational health protocols .
Mandatory Screening and Regulatory Framework
The UAE has integrated hepatitis screening into its medical fitness examination system for residency and certain occupational groups. Under Cabinet Resolution No. (75) of 2022, expatriates coming to the UAE for residency are subject to medical examinations that include viral hepatitis screening for specific groups . Additionally, hepatitis C testing has been mandated for workers in barbershops, beauty salons, and health clubs, alongside hepatitis B screening for healthcare practitioners in direct contact with patients .
Why Early Detection is Non-Negotiable
Viral hepatitis is often called a "silent epidemic" because it can progress for decades without overt symptoms. By the time patients present with jaundice, abdominal pain, or unexplained fatigue, significant liver damage — including fibrosis, cirrhosis, or hepatocellular carcinoma — may already have occurred . MoHAP consistently emphasizes that early detection is key to effective treatment and better outcomes .
The WHO recommends universal screening for hepatitis B and C for all adults, with specific emphasis on pregnant women and high-risk groups . In the UAE, screening is widely available through diagnostic laboratories like DNA Labs UAE, which offers comprehensive viral hepatitis testing panels using advanced serology and molecular PCR techniques .
🔬 Clinical Tip: The CDC recommends a triple-panel test for hepatitis B (HBsAg, anti-HBs, and total anti-HBc) to determine both infection and immunity status, and a two-step reflex testing sequence for hepatitis C (antibody test with automatic reflex to RNA testing if positive) .
Community Awareness and Digital Health Integration
The UAE leverages digital health solutions to support public health initiatives. The enhanced "Al Hosn" app now includes integrated tools for tracking immunization records for children and other community members, enabling seamless digital documentation and monitoring of vaccination data . This digital infrastructure supports the nation's commitment to achieving the WHO's goal of eliminating viral hepatitis as a public health threat by 2030 .
MoHAP continues to launch regular awareness campaigns, particularly around World Hepatitis Day, to educate the public on transmission routes, prevention strategies, and the importance of early screening .
The Path Forward: Breaking Down Barriers
Despite significant progress, global hepatitis elimination faces persistent challenges: stigma, limited awareness, health system gaps, and inequalities in access to care . The 2026 campaign theme "Let's Break It Down" calls for dismantling these barriers through:
- Political commitment and sustained investment in hepatitis services .
- Universal testing and treatment integrated into primary healthcare .
- Equitable access to prevention, diagnostics, and curative therapies .
- Reduction of stigma through education and community engagement .
The UAE's experience — exemplified by Egypt's gold-tier achievement in hepatitis C elimination, the first in the Eastern Mediterranean Region — underscores the power of coordinated action and sustained investment . As we mark World Hepatitis Day 2026, the message is clear: elimination is achievable, and it starts with awareness, testing, and breaking down the barriers that stand in the way of health equity.
Frequently Asked Questions on Viral Hepatitis
What is the difference between hepatitis B and hepatitis C?
Hepatitis B (HBV) is transmitted through blood, sexual contact, and from mother to child at birth. It can be prevented with a highly effective vaccine. Hepatitis C (HCV) is primarily bloodborne, often through unsafe injections or transfusions, and there is currently no vaccine for HCV. Both can cause chronic liver disease, but HCV has a higher rate of chronicity .
Who should get tested for viral hepatitis in the UAE?
The UAE mandates hepatitis B and C screening for certain groups, including healthcare workers, those in beauty and wellness professions, and expatriates applying for residency . The CDC recommends universal screening for all adults aged 18 and older, and for pregnant women during each pregnancy .
Is hepatitis curable?
Yes. Hepatitis C can be cured with highly effective direct-acting antiviral (DAA) medications, typically with a treatment course of 8-12 weeks. The CDC recommends that all patients, regardless of substance use, receive treatment .
Can hepatitis B be prevented?
Absolutely. The hepatitis B vaccine is highly effective and is part of the UAE's national immunization program since 1991. Vaccination coverage in the UAE has reached 98% . The vaccine is also recommended for all adults aged 19-59 .
What are the symptoms of viral hepatitis?
Many patients are asymptomatic in early stages. When symptoms do occur, they may include unexplained fatigue, jaundice (yellowing of skin and eyes), dark urine, abdominal pain, nausea, and vomiting. Chronic infection can lead to liver cirrhosis and liver cancer over time .
Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis, treatment, and personalized health recommendations. Testing and vaccination decisions should be made in consultation with your physician.
⚕️ Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.
Found this helpful? Book a test or consult our team.